Search results for:

bevacizumab

bevacizumab
Drug Name Form Strength Non-Formulary Restricted Renal Dosing REMS Therapeutic Interchange Notes
Avastin SOLUTION, INTRAVENOUS 25 mg/mL        
Mvasi SOLUTION, INTRAVENOUS 25 mg/ml          
Zirabev SOLUTION, INTRAVENOUS 25 mg/ml          
VIEW MORE Antineoplastic Agents
CLASS
100000
Additional Information:
  Generic Name Brand Name
Biosimilar (RMH preferred) bevacizumab-bvzr Zirabev
Biosimilar (approved alternate) bevacizumab-awwb Mvasi
Originator product (allowed for use by ophthalmology only) bevacizumab Avastin
Last updated: May. 5, 2026
  • Biosimilar Preference List RMH Preferred: Zirabev
  • Biosimilar Preference List RMH Approved Alternate: Mvasi
Lexi-Comp Online Search Micromedex DrugPoint Summary Micromedex CareNotes


For further information regarding Formweb
please contact support@rpharmy.com.
Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved